Olivia R. Brohlin

Olivia R. Brohlin

Auto-generated profile, based on publicly available information

Olivia R. Brohlin

Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 West Campbell Road, Richardson, Texas 75080, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2021 in ACS Nano
Verified
Journal Article
Closed access
MLMichael A. Luzuriaga
Michael A. Luzuriaga
FHFabian C. Herbert
Fabian C. Herbert
OBOlivia R. Brohlin
Olivia R. Brohlin
JGJashkaran Gadhvi
Jashkaran Gadhvi
THThomas Howlett
Thomas Howlett
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

22 September 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ASArezoo Shahrivarkevishahi
Arezoo Shahrivarkevishahi
MLMichael A. Luzuriaga
Michael A. Luzuriaga
FHFabian C. Herbert
Fabian C. Herbert
ATAlisia C. Tumac
Alisia C. Tumac
OBOlivia R. Brohlin
Olivia R. Brohlin
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

28 August 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
RWRaymond P. Welch
Raymond P. Welch
HLHamilton Lee
Hamilton Lee
MLMichael A. Luzuriaga
Michael A. Luzuriaga
OBOlivia R. Brohlin
Olivia R. Brohlin
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

28 April 2020 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
FHFabian Castro Herbert
Fabian Castro Herbert
OBOlivia R. Brohlin
Olivia R. Brohlin
TGTyler Galbraith
Tyler Galbraith
CBCandace Benjamin
Candace Benjamin
CRCesar A. Reyes
Cesar A. Reyes
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith

5 February 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
HLHamilton Lee
Hamilton Lee
ASArezoo Shahrivarkevishahi
Arezoo Shahrivarkevishahi
JLJenica L. Lumata
Jenica L. Lumata
MLMichael A. Luzuriaga
Michael A. Luzuriaga
LHLaurel M. Hagge
Laurel M. Hagge
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith
Many contrast agents for magnetic resonance imaging are based on gadolinium, however side effects limit their use in some patients. Organic radical contrast agents (ORCAs) are potential alternatives, but are reduced rapidly in physiological conditions and have low relaxivities as single molecule contrast agents. Herein, we use a supramolecular strategy where cucurbit[8]uril binds with nanomolar affinities to ORCAs and protects them against biological reductants to create a stable radical in vivo. We further overcame the weak contrast by conjugating this complex on the surface of a self-assembled biomacromolecule derived from the tobacco mosaic virus.

12 January 2022 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
OBOlivia R. Brohlin
Olivia R. Brohlin
RERyanne N. Ehrman
Ryanne N. Ehrman
FHFabian C. Herbert
Fabian C. Herbert
YWYalini H. Wijesundara
Yalini H. Wijesundara
ARArun Raja
Arun Raja
JGJeremiah J. Gassensmith
Jeremiah J. Gassensmith